Oral d-ribose causes depressive-like behavior by altering glycerophospholipid metabolism via the gut-brain axis

Oral d-ribose causes depressive-like behavior by altering glycerophospholipid metabolism via the gut-brain axis

Abstract Our previous work has shown that d-ribose (RIB)-induced depressive-like behaviors in mice. However, the relationship between variations in RIB levels and depression as well as potential RIB participation in depressive disorder is yet unknown. Here, a reanalysis of metabonomics data from dep...

Full description

Bibliographic Details
Main Authors:	Ke Xu, Yi Ren, Shuang Zhao, Jinzhou Feng, Qingyuan Wu, Xue Gong, Jianjun Chen, Peng Xie
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-01-01
Series:	Communications Biology
Online Access:	https://doi.org/10.1038/s42003-023-05759-1

Similar Items

Imipramine Treatment Alters Sphingomyelin, Cholesterol, and Glycerophospholipid Metabolism in Isolated Macrophage Lysosomes
by: Jacob M. Albright, et al.
Published: (2023-12-01)

Supraphysiologic doses of 17β-estradiol aggravate depression-like behaviors in ovariectomized mice possibly via regulating microglial responses and brain glycerophospholipid metabolism
by: Ming Li, et al.
Published: (2023-09-01)

Sphingolipid Catabolism and Glycerophospholipid Levels Are Altered in Erythrocytes and Plasma from Multiple Sclerosis Patients
by: Albena Momchilova, et al.
Published: (2022-07-01)

Multi-omics data reveals the disturbance of glycerophospholipid metabolism and linoleic acid metabolism caused by disordered gut microbiota in PM2.5 gastrointestinal exposed rats
by: Yannan Zhang, et al.
Published: (2023-09-01)

The Importance of Glycerophospholipid Production to the Mutualist Symbiosis of Trypanosomatids
by: Allan C. de Azevedo-Martins, et al.
Published: (2021-12-01)

Glycerophospholipids in the brain : phospholipases A2 in neurological disorders /
by: 180221 Farooqui, Akhlaq A., et al.
Published: (2007)

Synthesis of the glycerophospholipids with polymerizable groups for the stable nanoparticles formation.
by: N. A. Bragina, et al.
Published: (2008-04-01)

The role of gut microbiota in depression: an analysis of the gut-brain axis
by: Natasha Irum, et al.
Published: (2023-06-01)

The microbiota-gut-brain axis in stress and depression
by: Hwei-Ee Tan
Published: (2023-04-01)

Mutations of RAS genes identified in acute myeloid leukemia affect glycerophospholipid metabolism pathway
by: Tianqi Liang, et al.
Published: (2023-11-01)

Effect of psychological stress on the oral-gut microbiota and the potential oral-gut-brain axis
by: Durga Paudel, et al.
Published: (2022-11-01)

Multi-omics data reveals aberrant gut microbiota-host glycerophospholipid metabolism in association with neuroinflammation in APP/PS1 mice
by: Xiaohang Qian, et al.
Published: (2023-12-01)

Glycerophospholipids in Red Blood Cells Are Associated with Aerobic Performance in Young Swimmers
by: Álex Aparecido Rosini Silva, et al.
Published: (2024-03-01)

Biosynthesis and Significance of Fatty Acids, Glycerophospholipids, and Triacylglycerol in the Processes of Glioblastoma Tumorigenesis
by: Jan Korbecki, et al.
Published: (2023-04-01)

Verbascoside exerts an anti-atherosclerotic effect by regulating liver glycerophospholipid metabolism
by: Peng Lei, et al.
Published: (2023-11-01)

Genetic evidence for the oral-gut axis between periodontitis and inflammatory bowel disease
by: Zhongyuan Wang, et al.
Published: (2023-10-01)

(R)-Salbutamol Improves Imiquimod-Induced Psoriasis-Like Skin Dermatitis by Regulating the Th17/Tregs Balance and Glycerophospholipid Metabolism
by: Fei Liu, et al.
Published: (2020-02-01)

The Intervention of Prebiotics on Depression via the Gut–Brain Axis
by: Qinghui He, et al.
Published: (2022-06-01)

The role of the gut-brain axis in depression and anxiety disorders
by: M. Trigo
Published: (2021-04-01)

Gut-joint axis: Oral Probiotic ameliorates Osteoarthritis
by: Uzma Amin, et al.
Published: (2024-01-01)

Oral–Gut Microbiome Axis in Gastrointestinal Disease and Cancer
by: Se-Young Park, et al.
Published: (2021-04-01)

Oral–Gut Microbiome Axis in Gastrointestinal Disease and Cancer
by: Se-Young Park, et al.
Published: (2021-04-01)

Matrine alleviates depressive-like behaviors via modulating microbiota–gut–brain axis in CUMS-induced mice
by: Ming Zhang, et al.
Published: (2023-02-01)

Cuscutae semen alleviates CUS-induced depression-like behaviors in mice via the gut microbiota-neuroinflammation axis
by: Lanwei Hou, et al.
Published: (2023-02-01)

Alterations in the “Gut–Liver Axis” on Rats with Immunological Hepatic Fibrosis
by: Zhaoyao Qi, et al.
Published: (2023-01-01)

Dietary PUFA Preferably Modify Ethanolamine-Containing Glycerophospholipids of the Human Plasma Lipidome
by: Christine Dawczynski, et al.
Published: (2022-07-01)

Metabolic changes of glycerophospholipids during the reparative phase after myocardial infarction injury
by: Jin Wang, et al.
Published: (2023-06-01)

Biosynthesis of food constituents: Lipids. 2. Triacylglycerols, glycerophospholipids, and glyceroglycolipids - a review
by: Jan Velíšek, et al.
Published: (2006-12-01)

Alterations of oral and gut viromes in hypertension and/or periodontitis
by: Hui-Lin Ye, et al.
Published: (2024-01-01)

Prebiotic and Probiotic Modulation of the Microbiota–Gut–Brain Axis in Depression
by: Daniel E. Radford-Smith, et al.
Published: (2023-04-01)

The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder
by: Ewelina Młynarska, et al.
Published: (2022-05-01)

Neuroinflammation, Microbiota-Gut-Brain Axis, and Depression: The Vicious Circle
by: Sandy Reyes-Martínez, et al.
Published: (2023-05-01)

The oral-gut-circulatory axis: from homeostasis to colon cancer
by: Sofia C. Tortora, et al.
Published: (2023-11-01)

The oral-gut axis: a missing piece in the IBD puzzle
by: Sho Kitamoto, et al.
Published: (2023-11-01)

Untargeted Plasma Lipidomics Reveal Perturbed Metabolites of Glycerophospholipids, and Sphingolipids in Moderate-to-Severe Acne
by: Zhang D, et al.
Published: (2023-08-01)

Bariatric Surgery and Gut-Brain-Axis Driven Alterations in Cognition and Inflammation
by: Custers E, et al.
Published: (2023-11-01)

Alterations of the oral and gut mycobiome and cytokines during long-term follow-up of COVID-19 convalescents
by: Zhigang Ren, et al.
Published: (2023-04-01)

The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD) The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD) The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD)
by: T. Pieters, et al.
Published: (2022-06-01)

Oral-Systemic Health and Disorders: Latest Advances on Oral–Gut–Lung Microbiome Axis
by: Alessandra Amato
Published: (2022-08-01)

Alteration of the oral and gut microbiota in patients with Kawasaki disease
by: Qinghuang Zeng, et al.
Published: (2023-07-01)